SAFETY ANALYSIS OF LONG-TERM ROMIPLOSTIM USE IN PATIENTS WITH CHRONIC IMMUNE THROMBOCYTOPENIA (ITP)

被引：0
|
作者：
Rodeghiero, F. [1 ]
Provan, D. [2 ]
Cines, D. [3 ]
Stasi, R. [4 ]
Tarantino, M. [5 ]
Nie, K. [6 ]
Jun, S. [6 ]
机构：
[1] Dept Cell Therapy & Hematol, Vicenza, Italy
[2] Royal London Hosp, Ctr Haematol, London E1 1BB, England
[3] Dept Pathol & Lab Med, Philadelphia, PA USA
[4] St George Hosp, Dept Haematol, London, England
[5] Univ Illinois, Coll Med, Peoria, IL 61656 USA
[6] Amgen Inc, Thousand Oaks, CA 91320 USA
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2010年 / 95卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0184
引用
收藏
页码：73 / 74
页数：2
相关论文
共 50 条
  • [41] SAFETY AND EFFICACY OF LONG-TERM OPEN-LABEL DOSING OF ROMIPLOSTIM, ATHROMBOPOIETIN (TPO) - RECEPTOR AGONIST, IN THROMBOCYTOPENIC PEDIATRIC PATIENTS WITH IMMUNE THROMBOCYTOPENIA (ITP) IN AN EXTENSION STUDY
    Bussel, James
    Tarantino, Michael
    Geddis, Amy
    Guerrera, Michael
    Ikeda, Alan
    Nie, Kun
    Franklin, Janet
    Eisen, Melissa
    PEDIATRIC BLOOD & CANCER, 2015, 62 : 48 - 48
  • [42] Treatment patterns and clinical outcomes in patients with chronic immune thrombocytopenia (ITP) switched to eltrombopag or romiplostim
    David J. Kuter
    Cynthia Macahilig
    Kelly M. Grotzinger
    Sara A. Poston
    Peter Feng Wang
    Katie L. Dawson
    Melea Ward
    International Journal of Hematology, 2015, 101 : 255 - 263
  • [43] Repeated short-term use of eltrombopag in patients with chronic immune thrombocytopenia (ITP)
    Bussel, James B.
    Saleh, Mansoor N.
    Vasey, Sandra Y.
    Mayer, Bhabita
    Arning, Michael
    Stone, Nicole L.
    BRITISH JOURNAL OF HAEMATOLOGY, 2013, 160 (04) : 538 - 546
  • [44] Treatment patterns and clinical outcomes in patients with chronic immune thrombocytopenia (ITP) switched to eltrombopag or romiplostim
    Kuter, David J.
    Macahilig, Cynthia
    Grotzinger, Kelly M.
    Poston, Sara A.
    Wang, Peter Feng
    Dawson, Katie L.
    Ward, Melea
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2015, 101 (03) : 255 - 263
  • [45] ROMIPLOSTIM IN SPLENECTOMIZED (SPLNX) AND NONSPLENECTOMIZED (NONSPLNX) PATIENTS WITH IMMUNE THROMBOCYTOPENIA (ITP)
    Cines, D.
    Wasser, J.
    Rodeghiero, F.
    Chong, B.
    Steurer, M.
    Provan, D.
    Lyons, R.
    Garcia Chavez, J.
    Carpenter, N.
    Wang, X.
    Eisen, M.
    HAEMATOLOGICA, 2016, 101 : 194 - 194
  • [46] Romiplostim: A Bridge To Splenectomy In Three Patients With Refractory Immune Thrombocytopenia (ITP)
    Shah, Dhaval
    Rambally, Siayareh
    Mims, Martha
    Udden, Mark M.
    BLOOD, 2013, 122 (21)
  • [47] A single-arm, long-term efficacy and safety study of subcutaneous romiplostim in children with immune thrombocytopenia
    Grainger, John
    Bussel, James
    Tarantino, Michael
    Cooper, Nichola
    Beam, Donald
    Despotovic, Jenny
    Maschan, Alexey
    Wang, Kejia
    Eisen, Melissa
    Bowers, Charles
    BLOOD ADVANCES, 2023, 7 (03) : 396 - 405
  • [48] A PHARMACOECONOMIC EVALUATION OF ROMIPLOSTIM (NPLATE®) FOR THE TREATMENT OF CHRONIC IMMUNE THROMBOCYTOPENIA (ITP) IN MEXICO
    Arocho, R.
    Northridge, K.
    Rivera Hurtado, R.
    Garcia Chavez, J.
    VALUE IN HEALTH, 2011, 14 (03) : A62 - A62
  • [49] SAFETY AND EFFICACY OF LONG-TERM OPEN-LABEL DOSING OF ROMIPLOSTIM, A THROMBOPOIETIN (TPO)-RECEPTOR-AGONIST, IN THROMBOCYTOPENIC PEDIATRIC PATIENTS WITH IMMUNE THROMBOCYTOPENIA (ITP) IN AN EXTENSION STUDY
    Tarantino, Michael
    Bussel, James
    Geddis, Amy
    Guerrera, Michael
    Ikeda, Alan
    Nie, Kun
    Eisen, Melissa
    PEDIATRIC BLOOD & CANCER, 2014, 61 : S46 - S46
  • [50] Long-term outcome following splenectomy for chronic and persistent immune thrombocytopenia (ITP) in adults and children
    Ahmed, Rayaz
    Devasia, Anup J.
    Viswabandya, Auro
    Lakshmi, Kavitha M.
    Abraham, Aby
    Karl, Sampath
    Mathai, John
    Jacob, Paul M.
    Abraham, Deepak
    Srivastava, Alok
    Mathews, Vikram
    George, Biju
    ANNALS OF HEMATOLOGY, 2016, 95 (09) : 1429 - 1434
12345